Cannabis Use and Mental Illness: What We Now Know (and Don’t)
60 min
Tuesday, September 15, 2026
6:30 PM - 7:30 PM
Cannabis-related psychiatric complications are increasing due to rising THC potency, novel formulations, and widespread use among adolescents and young adults. This session reviews data on cannabis-induced psychosis, effects on depression and bipolar disorder, dose-response relationships, withdrawal, and risk reduction. Faculty will discuss assessment tools, cannabis tapering strategies, and treatment pathways for cannabis use disorder. Participants will gain practical guidance for counseling patients, addressing misconceptions, and integrating evidence-based interventions into clinical care.
-
Speaker
-
Ilan Melnick MD -
Andrew Penn MS, PMHNP-BC
-
-
Room
- Great Hall A